Biodistribution and Gene Expression of Lipid/Plasmid Complexes after Systemic Administration
- 20 September 1998
- journal article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 9 (14), 2083-2099
- https://doi.org/10.1089/hum.1998.9.14-2083
Abstract
The objectives of this study were to investigate the influence of physicochemical properties of lipid/plasmid complexes on in vivo gene transfer and biodistribution characteristics. Formulations based on 1,2-di-O-octadecenyl-3-trimethylammonium propane (DOTMA) and novel biodegradable cationic lipids, such as ethyl dioleoyl phosphatidylcholine (EDOPC), ethyl palmitoyl myristyl phosphatidylcholine (EPMPC), myristyl myristoyl carnitine ester (MMCE), and oleyl oleoyl L-carnitine ester (DOLCE), were assessed for gene expression after tail vein injection of lipid/plasmid complexes in mice. Gene expression was influenced by cationic lipid structure, cationic lipid-to-colipid molar ratios, plasmid-to-lipid charge ratios, and precondensation liposome size. Detectable levels of human growth hormone (hGH) in serum, human factor IX (hFIX) in plasma, and chloramphenicol acetyltransferase (CAT) in the lung and liver were observed with positively charged lipid/plasmid complexes prepared from 400-nm extruded liposomes with a cationic lipid-to-colipid ratio of 4:1 (mol/mol). Intravenous administration of lipid/CAT plasmid complexes resulted in distribution of plasmid DNA mainly to the lung at 15 min after injection. Plasmid DNA accumulation in the liver increased with time up to 24 hr postinjection. There was a 10-fold decrease in the amount of plasmid DNA in the lung at 15 min after injection, when the lipid/plasmid complex charge ratio was decreased from 3:1 to 0.5:1 (+/-). Bright fluorescent aggregates were evident in in vivo-transfected lung with the positively charged pCMV-CAT/DOLCE:dioleyl phosphatidylethanolamine (DOPE) (1:1, mol/mol) complexes, while more discrete punctate fluorescence was observed with a 4:1 molar ratio of cationic lipid:colipid formulations. Preinjection of polyanions such as plasmid, dextran sulfate, polycytidic acid, and polyinosinic acid decreased hGH expression, whereas the preinjection of both positively charged and neutral liposomes had no effect on hGH serum levels. Of the cationic lipids tested, DOLCE was found to be the most effective potentially biodegradable cationic lipid. A correlation between gene expression and cationic lipid:colipid ratios and lipid-to-plasmid charge ratio was also observed for DOTMA- and DOLCE-based formulations.Keywords
This publication has 45 references indexed in Scilit:
- Systemic Effect of Human Growth Hormone after Intramuscular Injection of a Single Dose of a Muscle-Specific Gene MedicineHuman Gene Therapy, 1998
- Effects of Complement Depletion on the Pharmacokinetics and Gene Delivery Mediated by Cationic Lipid–DNA ComplexesHuman Gene Therapy, 1998
- Improved DNA: liposome complexes for increased systemic delivery and gene expressionNature Biotechnology, 1997
- Factors influencing the efficiency of cationic liposome-mediated intravenous gene deliveryNature Biotechnology, 1997
- Mechanism of DNA Release from Cationic Liposome/DNA Complexes Used in Cell Transfection,Biochemistry, 1996
- A Novel Series of Amphiphilic Imidazolinium Compounds for in Vitro and in Vivo Gene DeliveryBiochemistry, 1995
- Cancer Gene Therapy Using Plasmid DNA: Safety Evaluation in Rodents and Non-Human PrimatesHuman Gene Therapy, 1995
- New structures in complex formation between DNA and cationic liposomes visualized by freeze—fracture electron microscopyFEBS Letters, 1994
- A novel cationic liposome reagent for efficient transfection of mammalian cellsBiochemical and Biophysical Research Communications, 1991
- Rapid Communication: In vivo Transfection of Murine Lungs with a Functioning Prokaryotic Gene using a Liposome VehicleThe American Journal of the Medical Sciences, 1989